Obstetrics and Gynecology

1046 questions

Question 41Question →

A 59-year-old postmenopausal woman with a family history of breast cancer and a recently confirmed BRCA1 pathogenic variant presents to her physician with early satiety, bloating, and increasing abdominal girth for the past month. Physical examination reveals a palpable, fixed, irregular left adnexal mass and a clinically detectable fluid wave indicating ascites. Arrange the following steps in the most appropriate chronological order for the diagnostic workup and standard management of this patient, from initial evaluation to post-remission therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Pelvic ultrasonography, followed by CT scan and CA-125, then Surgical cytoreduction, followed by Adjuvant chemotherapy, and concluding with PARP inhibitor maintenance.
The standard diagnostic and therapeutic pathway for suspected advanced ovarian cancer begins with transvaginal ultrasonography, which is the most sensitive initial imaging modality to characterize adnexal pathology. Following sonographic confirmation of a suspicious mass, a CT scan of the chest, abdomen, and pelvis along with serum CA-125 is necessary for pre-operative staging and assessing surgical resectability. The primary therapeutic intervention is then an exploratory laparotomy for maximal surgical cytoreduction (debulking), followed by adjuvant systemic platinum-based and taxane-based chemotherapy. Finally, in a patient with a confirmed BRCA mutation who has completed primary chemotherapy and achieved a response, maintenance therapy with a PARP inhibitor is indicated to substantially prolong progression-free survival.

Step-by-Step Solution

1
Identify the most appropriate initial diagnostic test for a suspected adnexal mass.
Pelvic ultrasonography is placed first.
Ultrasound is the primary modality to characterize adnexal masses and determine the initial risk of malignancy based on sonographic architecture.
2
Determine the necessary preoperative evaluation for a highly suspicious adnexal mass with ascites.
CT of the chest, abdomen, and pelvis with serum CA-125 is placed second.
Cross-sectional imaging is required to evaluate the extent of intra-abdominal and extra-abdominal metastasis to plan for surgical resectability.
3
Identify the primary therapeutic intervention.
Exploratory laparotomy for maximal surgical cytoreduction is placed third.
Surgical debulking is the standard of care for the primary treatment of advanced ovarian cancer, unless the disease is deemed entirely unresectable.
4
Select the appropriate post-surgical management.
Adjuvant systemic chemotherapy is placed fourth.
Platinum- and taxane-based chemotherapy is universally indicated following cytoreduction to eliminate residual disease in advanced ovarian carcinoma.
5
Identify the role of targeted therapy based on the patient's specific genetic profile.
PARP inhibitor maintenance therapy is placed last.
Because the patient has a known BRCA1 mutation, PARP inhibitor therapy is indicated strictly as maintenance after the completion of primary chemotherapy.

Key Concept

The standard chronological management of advanced epithelial ovarian cancer involves initial ultrasound evaluation, preoperative CT staging, maximal surgical cytoreduction, adjuvant platinum-based chemotherapy, and targeted maintenance therapy for patients with a BRCA mutation.
Question 42Question →

A 24-year-old nulliparous woman presents to the clinic reporting that she has not had a menstrual period for the past 6 months. Her menarche occurred at age 12, and her menses were previously regular, occurring every 28 days. She takes no medications, has no chronic medical conditions, and is sexually active with a male partner. Her vital signs and physical examination are unremarkable. Arrange the following diagnostic steps in the most appropriate chronological sequence for the evaluation of this patient's secondary amenorrhea, starting with the immediate first step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

1) Urine beta-hCG test, 2) Serum prolactin, TSH, and FSH levels, 3) Progestin withdrawal challenge, 4) Estrogen-progestin challenge test
The evaluation of secondary amenorrhea must follow a stepwise algorithmic approach to avoid unnecessary testing and misdiagnosis. First, a pregnancy test is universally mandatory for any woman of reproductive age presenting with amenorrhea. Second, initial laboratory evaluation with TSH, prolactin, and FSH identifies the most common systemic neuroendocrine causes, such as hypothyroidism, pituitary adenomas, or premature ovarian insufficiency. Third, a progestin challenge assesses for adequate endogenous estrogen production; if bleeding occurs, it confirms anovulation with adequate estrogen. Finally, if there is no withdrawal bleeding, an estrogen-progestin challenge distinguishes between a profound lack of estrogen (bleeding occurs) and an anatomic outflow tract obstruction such as Asherman syndrome (no bleeding occurs).

Step-by-Step Solution

1
Perform a urine beta-hCG test
Excludes pregnancy
Pregnancy must always be ruled out first in secondary amenorrhea, regardless of contraceptive use or patient history.
2
Measure serum prolactin, TSH, and FSH
Evaluates for systemic endocrine causes
Identifies common etiologies like hyperprolactinemia, hypothyroidism, and primary ovarian insufficiency.
3
Administer a progestin withdrawal challenge
Assesses endogenous estrogen levels
Determines if the endometrium has been sufficiently primed by endogenous estrogen to produce withdrawal bleeding.
4
Administer an estrogen-progestin challenge
Differentiates hypoestrogenism from outflow tract obstruction
If bleeding occurs after estrogen and progestin, the amenorrhea is due to low estrogen; if no bleeding occurs, an anatomic defect (like Asherman syndrome) is present.

Key Concept

The algorithmic approach to diagnosing secondary amenorrhea begins unconditionally with excluding pregnancy, followed by identifying common endocrine abnormalities, and subsequently assessing the hypothalamic-pituitary-ovarian axis and outflow tract integrity.
Question 43Question →

A 26-year-old woman evaluates at the urgent care center due to four days of copious, malodorous vaginal discharge associated with mild dysuria. Her medical history is unremarkable, and she recently became sexually active with a new male partner. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}). Speculum examination demonstrates frothy, yellow-green fluid pooled in the posterior vaginal fornix and several punctate macular hemorrhages on the cervix. A saline microscopy preparation of the fluid reveals multiple motile, pear-shaped, flagellated organisms slightly larger than polymorphonuclear leukocytes. Which of the following is the most appropriate pharmacological intervention?

Show answer & explanation

Answer: Prescribe oral metronidazole for the patient and concurrently treat her sexual partner

Answer

Prescribe oral metronidazole for the patient and concurrently treat her sexual partner.
The patient's presentation of a malodorous, frothy, yellow-green discharge, punctate cervical hemorrhages (colpitis macularis or 'strawberry cervix'), and motile flagellated organisms on a wet mount is definitively diagnostic of an infection with Trichomonas vaginalis. Because trichomoniasis is a sexually transmitted infection, systemic oral therapy (such as metronidazole) must be prescribed. Furthermore, it is critical to concurrently treat the patient's sexual partner(s) to eradicate the reservoir and prevent 'ping-pong' reinfection.

Step-by-Step Solution

1
Identify the pathogen based on the clinical signs and microscopic findings.
The combination of frothy, yellow-green discharge, a 'strawberry cervix' (colpitis macularis), and motile flagellated organisms is diagnostic for Trichomonas vaginalis.
Accurate identification of the organism is required to select the correct targeted antimicrobial therapy.
2
Determine the optimal pharmacological treatment for the identified pathogen.
Systemic oral metronidazole (or tinidazole) is the first-line treatment.
Systemic therapy is necessary because Trichomonas often infects the urethra and paravaginal glands where topical treatments cannot reach.
3
Determine if partner treatment is necessary based on the transmission route.
Concurrent treatment of all sexual partners is required.
Trichomoniasis is a highly contagious sexually transmitted infection; untreated partners will continuously reinfect the patient.

Key Concept

Diagnosis and management of Trichomoniasis, emphasizing the necessity of expedited partner therapy.
Question 44Question →

Review the following four patient profiles. Each patient is seeking a reliable method of contraception. Match each clinical scenario with the most medically appropriate contraceptive method based on the United States Medical Eligibility Criteria (US MEC) for Contraceptive Use.

Click a left item, then click its matching right item

Items

A 35-year-old woman with active estrogen receptor-positive breast cancer currently undergoing adjuvant tamoxifen therapy.
A 29-year-old woman with a history of a Roux-en-Y gastric bypass procedure two years ago, who reports severe baseline dysmenorrhea and heavy menstrual bleeding.
A 24-year-old woman taking phenytoin for generalized tonic-clonic seizures, who requests a highly effective, non-daily, non-intrauterine hormonal contraceptive.
A 38-year-old woman who smokes 20 cigarettes per day and specifically requests a daily oral contraceptive.

Matches

Show answer & explanation

Answer

The breast cancer patient receives the Copper IUD; the bariatric surgery patient receives the Levonorgestrel IUS; the patient on phenytoin receives the DMPA injection; and the 38-year-old smoker receives the Progestin-only pill.
Each assignment rigorously adheres to the US MEC guidelines. The Copper IUD avoids hormone exposure in active breast cancer; the LNG-IUS bypasses gastric malabsorption while treating dysmenorrhea; the DMPA injection provides sufficient hormone levels to overcome hepatic enzyme induction by phenytoin; and the progestin-only pill provides a requested oral method while avoiding the severe cardiovascular risks of estrogen in older smokers.

Step-by-Step Solution

1
Analyze the contraindications for the 35-year-old patient with breast cancer on tamoxifen.
Identify that all hormonal methods (both estrogen and progestin) are strictly contraindicated (MEC 4).
Current or recent breast cancer requires completely hormone-free contraception, making the Copper IUD the only appropriate choice among the options.
2
Evaluate the contraceptive needs of the 29-year-old patient with prior Roux-en-Y gastric bypass and dysmenorrhea.
Rule out oral contraceptives due to malabsorption (MEC 3) and select the Levonorgestrel-releasing IUS.
Non-oral systemic or local methods are required post-malabsorptive bariatric surgery. The levonorgestrel IUS is uniquely suited to treat her comorbid heavy bleeding and severe dysmenorrhea.
3
Assess the pharmacokinetic interactions for the 24-year-old on phenytoin.
Determine that phenytoin induces hepatic enzymes, reducing the efficacy of most hormonal methods, but select the DMPA injection.
DMPA maintains its efficacy despite enzyme induction due to its high systemic dose. It perfectly satisfies her request for a highly effective, non-daily, non-intrauterine method.
4
Apply age and lifestyle criteria to the 38-year-old smoker.
Recognize that combined oral contraceptives are contraindicated (MEC 4) and assign the Progestin-only pill.
Women over age 35 who smoke heavily (>= 15 cigarettes/day) have an unacceptably high risk of thromboembolism and myocardial infarction with estrogen. Since she specifically requested a pill, the progestin-only formulation is the correct choice.

Key Concept

Application of the US Medical Eligibility Criteria (MEC) for Contraceptive Use in patients with complex medical comorbidities, including malignancy, malabsorption, enzyme-inducing medications, and cardiovascular risk factors.
Question 45Question →

A 27-year-old female presents to the outpatient clinic reporting an absence of menstruation for the past seven months. She previously experienced predictable cycles every 29 days. She denies hot flashes, nipple discharge, vision changes, or recent alterations in body weight. Physical examination shows a normal female escutcheon, no signs of hyperandrogenism, and an unremarkable bimanual pelvic examination. Arrange the following diagnostic steps in the most appropriate sequential order for evaluating this patient's condition, starting with the mandatory initial test.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Human chorionic gonadotropin assay, 2) Thyrotropin, prolactin, and follicle-stimulating hormone evaluation, 3) Progestin withdrawal challenge, 4) Sequential estrogen and progestin administration.
The evaluation of secondary amenorrhea follows a logical, step-wise algorithm to isolate the underlying etiology. Because pregnancy is the most common cause of secondary amenorrhea, a human chorionic gonadotropin (hCG) assay is the mandatory first step. Once pregnancy is excluded, the clinician should measure serum thyrotropin (TSH), prolactin, and follicle-stimulating hormone (FSH) to identify hypothyroidism, hyperprolactinemia, and primary ovarian insufficiency or functional hypothalamic amenorrhea, respectively. If these initial screening laboratories are normal, a progestin challenge test (e.g., a short course of medroxyprogesterone acetate) is administered to assess the patient's endogenous estrogen status and the patency of the genital outflow tract. A patient with adequate estrogen will experience withdrawal bleeding. If no bleeding occurs, an estrogen-progestin challenge is performed to prime the endometrium. Bleeding after this combination indicates a hypoestrogenic state, whereas a continued absence of bleeding points to an anatomical outflow tract obstruction (e.g., Asherman syndrome).

Step-by-Step Solution

1
Exclude pregnancy
Human chorionic gonadotropin (hCG) testing is performed.
Pregnancy is the most common cause of secondary amenorrhea and must always be the first condition ruled out.
2
Assess for common endocrine disorders
Serum levels of thyrotropin (TSH), prolactin, and follicle-stimulating hormone (FSH) are measured.
This identifies central or peripheral endocrine issues such as hypothyroidism, hyperprolactinemia, and primary ovarian insufficiency.
3
Evaluate endogenous estrogen and outflow tract
A progestin challenge test is administered.
Withdrawal bleeding confirms adequate endogenous estrogen and a patent outflow tract. Lack of bleeding requires further testing to determine the cause.
4
Differentiate hypoestrogenism from anatomical obstruction
An estrogen-progestin challenge is administered.
Bleeding indicates the outflow tract is patent but the patient is hypoestrogenic. Lack of bleeding confirms an outflow tract obstruction, such as Asherman syndrome.

Key Concept

The step-wise diagnostic evaluation of secondary amenorrhea begins with excluding pregnancy, followed by initial endocrine screening (TSH, prolactin, FSH), and then sequential hormonal challenges to evaluate the hypothalamic-pituitary-ovarian axis and uterine outflow tract.
Estimated Time:1m 30s
Question 46Question →

Evaluate the following complex patient profiles. Match each clinical scenario with the single most appropriate, highly effective contraceptive method based on the WHO/CDC Medical Eligibility Criteria (MEC).

Click a left item, then click its matching right item

Items

A 29-year-old woman with systemic lupus erythematosus and a history of deep vein thrombosis. Laboratory testing confirms the presence of lupus anticoagulant. She has regular, normal-volume menstrual periods.
A 39-year-old woman who smokes 20 cigarettes daily. She is currently admitted to the hospital receiving intravenous antibiotics for an acute tubo-ovarian abscess.
A 42-year-old woman with a blood pressure of 155/95 mmHg, severe heavy menstrual bleeding causing anemia, and a documented history of Wilson disease.
A 26-year-old woman with sickle cell disease and epilepsy managed with phenytoin. Pelvic ultrasound reveals a 5-cm submucosal leiomyoma significantly distorting the uterine cavity.

Matches

Show answer & explanation

Answer

The correct matches are: SLE/Antiphospholipid patient → Copper IUD; 39-year-old smoker with PID → Etonogestrel implant; Hypertensive with Wilson disease → Levonorgestrel IUD; Phenytoin user with distorted cavity → Depot medroxyprogesterone acetate.
Each clinical scenario requires the synthesis of at least two competing contraindications. The SLE patient with lupus anticoagulant requires a hormone-free method (Copper IUD) due to severe thrombophilia. The smoker with an active tubo-ovarian abscess cannot safely receive estrogen or an IUD, leaving the subdermal implant. The hypertensive patient with Wilson disease requires an LNG-IUD for medical management of bleeding while avoiding copper and estrogen. The patient on phenytoin with a distorted cavity requires DMPA to bypass both hepatic enzyme induction and anatomic constraints.

Step-by-Step Solution

1
Evaluate the systemic lupus erythematosus (SLE) patient with antiphospholipid antibodies.
Identify that both estrogen (MEC 4) and progestin-only methods (MEC 3) are restricted due to severe thrombophilia risk.
This leaves the non-hormonal Copper IUD as the only highly effective, MEC 1 option.
2
Evaluate the 39-year-old smoker with active pelvic inflammatory disease (PID).
Identify that age >35 plus smoking >15 cigarettes/day contraindicates estrogen (MEC 4), and active PID contraindicates IUD initiation (MEC 4).
This leaves the etonogestrel subdermal implant as the optimal MEC 1 option.
3
Evaluate the hypertensive patient with heavy bleeding and Wilson disease.
Identify that hypertension contraindicates estrogen (MEC 3), while Wilson disease strictly contraindicates the Copper IUD (MEC 4).
The levonorgestrel IUD is MEC 1 for hypertension, treats the heavy menstrual bleeding, and contains no copper.
4
Evaluate the patient taking phenytoin with a distorted uterine cavity.
Identify that phenytoin (CYP450 inducer) reduces the efficacy of most systemic hormones (MEC 3), and a distorted cavity contraindicates all IUDs (MEC 4).
Depot medroxyprogesterone acetate (DMPA) bypasses hepatic enzyme induction to maintain efficacy and is unaffected by uterine anatomy.

Key Concept

Advanced application of the Medical Eligibility Criteria (MEC) for contraceptive use in patients with overlapping medical comorbidities, anatomic abnormalities, and drug interactions.
Estimated Time:2m 0s
Question 47Question →

A 24-year-old healthy female presents to the clinic reporting an absence of menses for the past six months. She previously had regular 28-day menstrual cycles. She does not take any medications, has no chronic medical conditions, and reports no breast discharge, visual changes, or hot flashes. Physical examination reveals a normal body mass index and normal secondary sexual characteristics. Arrange the following diagnostic steps in the most appropriate chronological sequence for the initial evaluation of this patient's secondary amenorrhea, starting with the most immediate first step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: beta-hCG testing, followed by TSH and prolactin measurement, then a progestin withdrawal test, and finally an FSH assessment.
The algorithm for secondary amenorrhea mandates a logical, cost-effective progression. Pregnancy is ruled out first because it is the most common etiology. Next, easily treatable systemic conditions (thyroid and pituitary adenomas) are evaluated via TSH and prolactin. Once these are excluded, the progestin challenge determines if the ovaries are producing estrogen. Only if estrogen is lacking (no withdrawal bleed) is FSH required to determine if the failure is at the level of the ovary or the brain.

Step-by-Step Solution

1
Exclude pregnancy.
Beta-hCG test is ordered as the first step.
Pregnancy is the most prevalent cause of secondary amenorrhea in women of reproductive age. It must always be ruled out before any other diagnostics or hormonal treatments are initiated.
2
Evaluate for common endocrine disorders.
TSH and prolactin levels are drawn.
Thyroid disorders and hyperprolactinemia are frequent, easily identifiable, and highly treatable causes of secondary amenorrhea that can disrupt the hypothalamic-pituitary-ovarian axis.
3
Assess estrogen status and outflow tract patency.
A progestin withdrawal test (e.g., a 10-day course of medroxyprogesterone acetate) is administered.
Withdrawal bleeding confirms adequate endogenous estrogen production and an intact outflow tract (typical of anovulation/PCOS). Absence of bleeding indicates hypoestrogenism or an anatomic abnormality.
4
Localize the defect if the progestin challenge is negative.
FSH levels are checked.
Measuring FSH distinguishes between an ovarian etiology (hypergonadotropic hypogonadism, high FSH) and a hypothalamic/pituitary etiology (hypogonadotropic hypogonadism, low/normal FSH).

Key Concept

The stepwise evaluation of secondary amenorrhea always begins with a pregnancy test, followed by systemic endocrine screening (TSH/Prolactin), and subsequent anatomic/estrogen evaluation using hormonal challenges and gonadotropin levels.
Question 48Question →

A 2626-year-old nulligravid woman presents to the gynecologist reporting the absence of menses for the past 66 months. Prior to this, she had regular menstrual cycles occurring every 2828 days. Over the same 66-month period, she has noted a significant increase in thick, dark hair on her face, chest, and abdomen, as well as a noticeable deepening of her voice. She has also experienced a receding hairline. She has no significant past medical history and takes no medications or supplements. Vital signs are within normal limits. Her BMI is 23 kg/m223 \text{ kg/m}^2. Physical examination reveals temporal balding, severe hirsutism on the face and trunk, and clitoromegaly. Bimanual pelvic examination is limited by patient discomfort but reveals no obvious adnexal masses. A urine human chorionic gonadotropin test is negative. Serum thyroid-stimulating hormone (TSH) and prolactin levels are within normal limits. Which of the following is the most appropriate next step in the evaluation of this patient?

Show answer & explanation

Answer: Measurement of serum testosterone and dehydroepiandrosterone sulfate

Answer

Measurement of serum testosterone and dehydroepiandrosterone sulfate
The correct next step is the measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEAS). This patient presents with secondary amenorrhea and rapid-onset, severe hyperandrogenism leading to frank virilization (evidenced by clitoromegaly, deepening of the voice, and temporal balding). While mild, chronic hirsutism is commonly caused by polycystic ovary syndrome (PCOS) or non-classic congenital adrenal hyperplasia (NCCAH), rapid-onset virilization is a major red flag for an androgen-secreting neoplasm. These tumors can arise from the ovaries (e.g., Sertoli-Leydig cell tumors) or the adrenal glands (e.g., adrenal adenoma or carcinoma). Measuring serum testosterone and DHEAS helps differentiate the source: markedly elevated testosterone points to an ovarian etiology, whereas markedly elevated DHEAS points to an adrenal etiology.

Step-by-Step Solution

1
Identify the patient's primary presenting syndrome.
The patient has secondary amenorrhea accompanied by rapid-onset (66 months) severe hyperandrogenism, characterized by frank virilization (clitoromegaly, deepening voice, male-pattern balding).
Recognizing the severity and tempo of hyperandrogenism is critical for narrowing the differential diagnosis.
2
Differentiate between benign and neoplastic causes of hyperandrogenism.
Benign causes like polycystic ovary syndrome (PCOS) and non-classic congenital adrenal hyperplasia (NCCAH) typically present with a slow, insidious onset of mild to moderate hirsutism and acne, lacking frank virilization. Rapid-onset virilization strongly suggests an androgen-secreting neoplasm.
This distinction prevents misdiagnosis of common conditions like PCOS in patients harboring a potentially life-threatening tumor.
3
Determine the necessary laboratory tests to identify the source of the suspected neoplasm.
Measurement of serum total testosterone and dehydroepiandrosterone sulfate (DHEAS) is indicated.
Markedly elevated testosterone levels (typically >150 ng/dL150 \text{ ng/dL}) suggest an ovarian source (e.g., Sertoli-Leydig cell tumor), whereas markedly elevated DHEAS levels (typically >700 mcg/dL700 \text{ mcg/dL}) suggest an adrenal source (e.g., adrenal adenoma or carcinoma).

Key Concept

Rapid-onset hirsutism with signs of virilization (such as clitoromegaly, temporal balding, and deepening of the voice) requires immediate evaluation for an androgen-secreting tumor of ovarian or adrenal origin using serum testosterone and DHEAS levels.
Question 49Question →

A 27-year-old primigravid woman at 39 weeks gestation is admitted to the labor and delivery unit in spontaneous labor. She requests and receives epidural anesthesia for pain management. Her labor progresses without complication, and her cervix becomes completely dilated. She is instructed to begin pushing. Three hours later, a vaginal examination reveals the cervix is 10 cm dilated and 100% effaced, and the fetal head is at +2 station in the direct occiput anterior position. The maternal temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, and pulse is 84/min. Uterine contractions occur every 2 to 3 minutes and are strong to palpation. Continuous fetal heart rate monitoring demonstrates a baseline of 135/min, moderate variability, and symmetric, gradual decreases in the fetal heart rate that begin and end with each uterine contraction. The nadir of these decreases coincides precisely with the peak of each contraction. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Continued maternal pushing

Answer

The correct answer is continued maternal pushing.
The correct answer is continued maternal pushing because the patient has not yet met the diagnostic criteria for second-stage labor arrest. According to current American College of Obstetricians and Gynecologists (ACOG) guidelines, an arrest of the second stage in a nulliparous woman with epidural anesthesia is diagnosed only after at least 4 hours of pushing. Because she has been pushing for 3 hours, has adequate contractions, and has a Category I fetal heart rate tracing (baseline 135/min, moderate variability, and early decelerations due to head compression), the most appropriate management is to allow her to continue pushing.

Step-by-Step Solution

1
Interpret the fetal heart rate (FHR) tracing to determine fetal status.
The FHR shows a normal baseline, moderate variability, and early decelerations (gradual decreases that mirror the contractions). This is a reassuring Category I tracing.
Early decelerations are a benign result of fetal head compression during the second stage of labor and do not require intervention.
2
Assess the adequacy of uterine contractions.
Contractions are occurring every 2 to 3 minutes and are palpated as strong, indicating adequate uterine activity.
This rules out the need for uterotonic augmentation (e.g., oxytocin).
3
Apply the diagnostic criteria for second-stage arrest based on parity and epidural status.
The patient is a nulliparous woman with an epidural. Current guidelines define second-stage arrest in this population as the lack of progress after 4 hours of pushing.
Since she has only been pushing for 3 hours, she has not yet met the criteria for an arrest disorder.
4
Determine the next best step in management.
Expectant management with continued maternal pushing.
Because both maternal and fetal statuses are reassuring and the patient is within the normal temporal limits for the second stage of labor, no medical or surgical intervention is indicated at this time.

Key Concept

The diagnosis of second-stage arrest of labor requires specific time limits: at least 4 hours of pushing in nulliparous women with an epidural (or 3 hours without), and at least 3 hours in multiparous women with an epidural (or 2 hours without).
Question 50Question →

Match each clinical presentation of a breast disorder to the most appropriate initial diagnostic workup or management step.

Click a left item, then click its matching right item

Items

22-year-old woman with a newly discovered 2-cm firm, mobile, well-circumscribed palpable breast mass
32-year-old woman with bilateral, multi-ductal milky nipple discharge and no palpable breast masses
45-year-old woman with a new 3-cm firm, poorly circumscribed, painless palpable breast mass
26-year-old exclusively breastfeeding woman with fever, localized breast erythema, and a fluctuant, tender 4-cm mass

Matches

Show answer & explanation

Answer

Left 1 matches with Targeted breast ultrasound; Left 2 matches with Serum prolactin, TSH, and pregnancy testing; Left 3 matches with Diagnostic mammography and targeted breast ultrasound; Left 4 matches with Needle aspiration and empiric antibiotic therapy.
Each clinical scenario corresponds to a specific, guideline-directed management pathway based on age, symptom characteristics, and reproductive status.

Step-by-Step Solution

1
Evaluate the 22-year-old patient with a palpable breast mass.
Determine that the patient's age (< 30 years) necessitates targeted breast ultrasound as the first-line imaging.
Dense breast tissue in younger women lowers mammographic sensitivity and increases radiation risks, making ultrasound the standard initial test.
2
Assess the 32-year-old patient with milky nipple discharge.
Recognize this as physiologic galactorrhea, requiring endocrine evaluation before any imaging.
Bilateral, multiductal, milky discharge without a mass is rarely malignant and is typically driven by hormonal abnormalities.
3
Evaluate the 45-year-old patient with a palpable breast mass.
Select diagnostic mammography and targeted breast ultrasound.
For women aged 30 and older, both modalities are used to fully characterize the mass and screen for synchronous lesions in the ipsilateral or contralateral breast.
4
Evaluate the 26-year-old breastfeeding patient with a fluctuant mass and fever.
Identify a breast abscess and select needle aspiration with empiric antibiotics.
A localized, fluctuant collection in the setting of mastitis indicates an abscess that must be mechanically drained and treated with antibiotics targeting skin flora.

Key Concept

The initial evaluation of breast symptoms strictly depends on patient age (ultrasound for <30 vs. mammogram + ultrasound for >=30), the physiologic vs. pathologic nature of nipple discharge, and identifying signs of localized infection requiring drainage.
Question 51Question →

A 34-year-old woman, gravida 2, para 1, undergoes suction dilation and curettage for an early pregnancy loss at 9 weeks gestation. The procedure is performed under general anesthesia. Cervical dilation is uncomplicated. However, during suctioning, the physician notes a sudden loss of resistance, and the cannula advances significantly further than the previously measured uterine depth. The suction is immediately turned off. Inspection of the aspirated contents in the tubing reveals fragments of yellow, fatty tissue. The patient's blood pressure is 118/76 mm Hg and heart rate is 82/min. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Diagnostic laparoscopy

Answer

Diagnostic laparoscopy
Uterine perforation is a known complication of dilation and curettage. The management depends on the instrument used and the patient's clinical status. A perforation caused by a blunt instrument (e.g., uterine sound) in a hemodynamically stable patient can often be managed with observation. However, a perforation caused by a sharp instrument or a suction device carries a high risk of injury to surrounding intra-abdominal organs (bowel, bladder, blood vessels). The retrieval of yellow, fatty tissue (omentum) confirms that the instrument has entered the abdominal cavity and pulled extrauterine structures. In a hemodynamically stable patient, the most appropriate next step is diagnostic laparoscopy to carefully inspect the bowel and other viscera for injury and repair them as needed.

Step-by-Step Solution

1
Identify the complication occurring during the procedure.
The loss of resistance and excessive advancement of the cannula indicate a uterine perforation.
Recognizing the physical signs of perforation is the first step in intraoperative complication management.
2
Determine the severity and type of the perforation based on the aspirate.
The presence of 'yellow, fatty tissue' (omentum or bowel appendices) in the suction tubing indicates a complicated perforation involving intra-abdominal structures.
Differentiation between a simple (blunt instrument, no bleeding) and complicated (sharp/suction instrument, visceral involvement) perforation guides management.
3
Select the appropriate intervention based on the patient's hemodynamic status.
Because the patient is hemodynamically stable, diagnostic laparoscopy is indicated to visually assess and repair any bowel or visceral injury.
Laparoscopy is preferred over laparotomy in stable patients to minimize surgical morbidity while allowing for direct visualization and repair.

Key Concept

Management of a complicated uterine perforation with suspected visceral injury requires immediate intraoperative visual assessment of the abdominal cavity, typically via laparoscopy in stable patients.
Estimated Time:1m 15s
Question 52Question →

A 32-year-old woman, gravida 0, comes to the physician for evaluation of infertility. She and her husband have been trying to conceive for 14 months without success. Her last menstrual period was 8 months ago; prior to this, her periods occurred regularly every 28 days. She reports a 9-kg (20-lb) weight gain over the past year, along with worsening fatigue and cold intolerance. She also notes mild facial acne and intermittent morning headaches. She says, "I've been bumping into doorframes a lot lately." Her temperature is 36.4°C (97.5°F), blood pressure is 110/70 mm Hg, and pulse is 58/min. Her body mass index is 29 kg/m². Physical examination reveals delayed relaxation of deep tendon reflexes. Visual field testing by confrontation demonstrates decreased peripheral vision bilaterally.

Laboratory studies:
Urine pregnancy test: negative
Follicle-stimulating hormone: 3 mIU/mL
Luteinizing hormone: 2 mIU/mL
Prolactin: 48 ng/mL (Normal: < 20 ng/mL)
Thyroid-stimulating hormone: 0.2 µU/mL (Normal: 0.5–5.0 µU/mL)
Free thyroxine (T4): 0.6 ng/dL (Normal: 0.9–1.7 ng/dL)

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Magnetic resonance imaging of the brain

Answer

Magnetic resonance imaging of the brain
The most appropriate next step in management is magnetic resonance imaging of the brain. This patient presents with secondary amenorrhea, hypogonadotropic hypogonadism (low FSH and LH), secondary hypothyroidism (low TSH and low free T4), and mild hyperprolactinemia. Furthermore, she has classic signs of a pituitary mass effect, including headaches and bitemporal hemianopsia ('bumping into doorframes'). This clinical picture is highly suspicious for a pituitary macroadenoma (such as a nonfunctioning adenoma). The mass compresses the optic chiasm (causing visual field defects), destroys normal anterior pituitary tissue (causing hypogonadotropic hypogonadism and central hypothyroidism), and compresses the pituitary stalk. Stalk compression disrupts the normal tonic inhibitory flow of dopamine from the hypothalamus to the lactotrophs, leading to mild hyperprolactinemia (typically < 200 ng/mL), known as the 'stalk effect'. Therefore, neuroimaging with a dedicated pituitary MRI is required to evaluate the size and extent of the mass before any surgical or specific medical intervention is attempted.

Step-by-Step Solution

1
Analyze the patient's laboratory results.
The patient has low free T4 with inappropriately low TSH (central hypothyroidism), low FSH/LH with amenorrhea (hypogonadotropic hypogonadism), and mildly elevated prolactin.
To identify the pathophysiological origin of the patient's infertility and symptoms.
2
Evaluate the physical examination findings.
The presence of bitemporal hemianopsia (decreased peripheral vision) and headaches points to a mass compressing the optic chiasm.
To correlate laboratory abnormalities with structural anatomic findings.
3
Synthesize findings to formulate a diagnosis.
The combination of multiple anterior pituitary hormone deficiencies, mild hyperprolactinemia (stalk effect), and optic chiasm compression indicates a pituitary macroadenoma.
To determine the underlying etiology of the patient's presentation.
4
Select the most appropriate next step in management.
Magnetic resonance imaging of the brain is the best next step.
Neuroimaging is required to confirm the presence, size, and anatomical extent of the pituitary mass before initiating therapy.

Key Concept

Evaluation of central amenorrhea and secondary hypothyroidism due to a pituitary macroadenoma.
Question 53Question →

A 23-year-old graduate student is evaluated in the ambulatory care clinic due to bothersome facial hair and infrequent menstrual periods. Her menarche occurred at age 12, and she reports having only three to four menses per year since that time. Over the last 24 months, she has observed increasing coarse, dark hair on her upper lip, chin, and lower abdomen, prompting her to shave frequently. Her past medical history is unremarkable, and she takes no medications. Vital signs show a blood pressure of 118/76 mmHg118/76 \text{ mmHg}, a pulse of 74/min74/\text{min}, and a respiratory rate of 14/min14/\text{min}. Her body mass index is 29 kg/m229 \text{ kg/m}^2. Physical examination confirms moderate inflammatory acne over the face and back, as well as terminal hairs in a male-pattern distribution. Pelvic examination is normal, with no evidence of clitoromegaly or palpable adnexal masses. A urine human chorionic gonadotropin test is negative. Laboratory results show normal serum thyroid-stimulating hormone and prolactin levels. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Measurement of serum 17-hydroxyprogesterone

Answer

Measurement of serum 17-hydroxyprogesterone
The correct answer is measurement of serum 17-hydroxyprogesterone. This patient presents with oligo-ovulation and clinical hyperandrogenism, making polycystic ovary syndrome (PCOS) the most likely diagnosis. However, PCOS is a diagnosis of exclusion. Before confirming PCOS, other causes of hyperandrogenism must be ruled out, including non-classic congenital adrenal hyperplasia (NCCAH), thyroid dysfunction, and hyperprolactinemia. Since thyroid-stimulating hormone and prolactin levels are already normal, checking 17-hydroxyprogesterone is required to exclude NCCAH (late-onset 21-hydroxylase deficiency).

Step-by-Step Solution

1
Identify the primary clinical presentation and generate a differential diagnosis.
The patient exhibits oligo-ovulation (irregular menses) and clinical hyperandrogenism (hirsutism, acne), pointing to polycystic ovary syndrome (PCOS) as the most likely diagnosis.
Establishing the core symptoms is necessary to guide the diagnostic workup according to standard endocrine protocols.
2
Apply diagnostic criteria and identify necessary exclusion tests.
PCOS is a diagnosis of exclusion. Pregnancy, thyroid disorders, and hyperprolactinemia have already been excluded by normal initial laboratory results.
The Rotterdam criteria require the exclusion of other medical conditions that can cause hyperandrogenism and irregular menses before confirming PCOS.
3
Select the appropriate laboratory test to rule out remaining diagnostic mimics.
Non-classic congenital adrenal hyperplasia (NCCAH) must be excluded by measuring serum 17-hydroxyprogesterone.
NCCAH, primarily caused by late-onset 21-hydroxylase deficiency, presents identically to PCOS and is a critical condition to rule out.

Key Concept

Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion; confirming the diagnosis requires ruling out mimics such as thyroid dysfunction, hyperprolactinemia, and non-classic congenital adrenal hyperplasia (via 17-hydroxyprogesterone testing).
Question 54Question →

A 29-year-old nulliparous woman at 27 weeks of gestation comes to the obstetric clinic for a scheduled evaluation. She mentions that lately she feels "out of breath" when climbing stairs at home and has noticed her shoes feeling tight by the evening. She has no history of cardiopulmonary disease. Blood pressure is 114/72 mm Hg, pulse is 98/min, and respirations are 20/min. Cardiopulmonary auscultation reveals a grade 2/6 systolic murmur heard best over the left sternal border and clear breath sounds bilaterally. Trace pitting edema is noted around her ankles.

Laboratory analysis shows:
Leukocyte count: 14,200/mm314,200/\text{mm}^3
Hemoglobin: 10.7 g/dL10.7 \text{ g/dL}
Platelet count: 128,000/mm3128,000/\text{mm}^3
Serum creatinine: 0.5 mg/dL0.5 \text{ mg/dL}
Urine dipstick: 1+ glucose, negative for protein and blood.

Her blood type is O, Rh-positive.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Order an oral glucose challenge test for gestational diabetes screening

Answer

The correct answer is to order an oral glucose challenge test for gestational diabetes screening.
The correct answer is to proceed with routine screening, which includes a 50-g oral glucose challenge test. This patient presents with multiple clinical and laboratory findings that, while appearing abnormal in a non-pregnant patient, represent normal physiologic adaptations to pregnancy. Her dyspnea is due to progesterone-induced increased tidal volume. The 2/6 systolic murmur is a physiologic flow murmur resulting from increased cardiac output. The trace edema is due to decreased plasma oncotic pressure and inferior vena cava compression. Furthermore, her laboratory findings show a normal dilutional anemia of the second trimester (hemoglobin > 10.5 g/dL is normal), mild physiologic leukocytosis, gestational thrombocytopenia, decreased serum creatinine (due to increased GFR), and normal physiologic glycosuria. Because all findings are physiologic, she requires standard prenatal care, which at 24 to 28 weeks gestation mandates universal screening for gestational diabetes mellitus.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has mild dyspnea, trace edema, and a 2/6 systolic murmur with normal vitals.
To differentiate between normal physiologic adaptations of pregnancy and potential cardiopulmonary pathology.
2
Evaluate the laboratory findings against pregnancy-specific reference ranges.
Hemoglobin (10.7 g/dL) is normal for the second trimester (>10.5 g/dL). Mild leukocytosis, thrombocytopenia, decreased creatinine, and trace glycosuria are also present and normal.
To identify any true hematologic or renal abnormalities requiring intervention.
3
Synthesize the findings to determine the patient's overall health status.
All clinical and laboratory findings reflect normal physiologic adaptations to pregnancy. No acute pathology is present.
To avoid unnecessary diagnostic testing for expected pregnancy changes.
4
Apply the standard prenatal care timeline to a normal pregnancy at 27 weeks gestation.
The 24 to 28-week window requires universal screening for gestational diabetes mellitus.
To select the most appropriate proactive management step for this specific routine visit.

Key Concept

Normal physiologic adaptations to pregnancy and the standard prenatal screening timeline
Question 55Question →

Match each clinical scenario describing an acute obstetric complication with its most appropriate immediate next step in management.

Click a left item, then click its matching right item

Items

A patient at 38 weeks gestation develops generalized tonic-clonic seizures with severe hypertension.
During vaginal delivery, the fetal head retracts against the maternal perineum and the anterior shoulder fails to deliver.
Significant vaginal bleeding occurs immediately after placental delivery, and the uterus feels soft and boggy on palpation.
A patient at 31 weeks gestation presents with sudden-onset, painless, bright red vaginal bleeding.

Matches

Show answer & explanation

Answer

Eclamptic seizures require magnesium sulfate. Shoulder dystocia is managed initially with McRoberts maneuver and suprapubic pressure. Uterine atony requires bimanual massage and uterotonics. Suspected placenta previa requires ultrasound prior to any digital cervical examination.
Each management step addresses the immediate life-threatening aspect of the matched complication: magnesium sulfate stabilizes eclamptic neuro-excitability, the McRoberts maneuver mechanically alters the maternal pelvis to resolve shoulder dystocia, physical massage and uterotonics directly counter uterine atony, and ultrasound ensures safety before evaluating a bleeding patient.

Step-by-Step Solution

1
Identify the underlying obstetric complication described in each clinical scenario.
Scenario 1 describes eclampsia, Scenario 2 describes shoulder dystocia, Scenario 3 describes uterine atony causing postpartum hemorrhage, and Scenario 4 describes possible placenta previa.
Accurate diagnosis based on hallmark clinical signs is required before determining the appropriate therapeutic intervention.
2
Determine the standard first-line management for each identified complication.
Magnesium sulfate for eclampsia; McRoberts maneuver for shoulder dystocia; bimanual massage and uterotonics for atony; ultrasound for painless third-trimester bleeding.
USMLE guidelines emphasize prioritizing interventions that immediately stabilize the patient or prevent catastrophic harm.

Key Concept

Recognizing classic presentations of major obstetric emergencies and selecting their immediate, first-line management.
Question 56Question →

Match each clinical presentation of a pregnant patient with the primary underlying physiological mechanism responsible for the findings.

Click a left item, then click its matching right item

Items

A 28-year-old G1P0 at 32 weeks gestation complains of feeling "short of breath." Vitals are normal. Lungs are clear. Arterial blood gas reveals pH 7.44, PaCO2 29 mmHg, PaO2 104 mmHg, and HCO3 20 mEq/L.
A 25-year-old G2P1 at 18 weeks gestation reports occasional dizziness when standing rapidly. Blood pressure is 98/58 mmHg, which is lower than her pre-pregnancy baseline of 115/75 mmHg.
A 31-year-old G1P0 at 26 weeks gestation has a routine CBC showing hemoglobin 10.6 g/dL, hematocrit 32%, and MCV 89 fL. Her serum ferritin level is 45 ng/mL (normal: 15-200 ng/mL).
A 29-year-old G3P2 at 36 weeks gestation notes prominent swelling of both ankles by the end of the day. Blood pressure is 112/68 mmHg, and a dipstick urinalysis shows trace protein.

Matches

Show answer & explanation

Answer

The presentations map to their physiological causes as follows: The dyspnea and respiratory alkalosis match progesterone-mediated respiratory drive; the second-trimester hypotension matches decreased systemic vascular resistance; the normocytic anemia with normal ferritin matches disproportionate plasma volume expansion; and the third-trimester dependent edema matches mechanical venous compression.
Each clinical scenario corresponds to a well-defined physiologic adaptation in pregnancy. The respiratory alkalosis is driven by progesterone; the mid-pregnancy blood pressure nadir is due to decreased systemic vascular resistance; the normocytic anemia is from disproportionate plasma volume expansion; and the dependent edema is due to mechanical compression of the inferior vena cava.

Step-by-Step Solution

1
Analyze the respiratory presentation (32 weeks with dyspnea and ABG).
The patient has mild dyspnea and a compensated respiratory alkalosis (low PaCO2, low HCO3, normal-high pH).
This is a classic normal physiologic change of pregnancy driven by progesterone, ruling out pathological causes like pulmonary embolism.
2
Analyze the cardiovascular presentation (18 weeks with dizziness).
The patient has asymptomatic to mildly symptomatic hypotension in the second trimester.
Blood pressure normally reaches a nadir at mid-pregnancy due to a significant drop in systemic vascular resistance.
3
Analyze the hematologic presentation (26 weeks with low hemoglobin).
The patient has anemia with normal MCV and normal iron stores (ferritin).
This confirms physiologic dilutional anemia due to disproportionate plasma volume expansion, differentiating it from iron deficiency anemia.
4
Analyze the renal/extremity presentation (36 weeks with ankle swelling).
The patient has trace proteinuria and dependent edema without hypertension.
Trace protein can be normal in pregnancy, and third-trimester edema is caused by mechanical compression of the IVC, ruling out preeclampsia.

Key Concept

Normal maternal physiological adaptations to pregnancy can mimic pathological states; they include progesterone-mediated respiratory alkalosis, decreased systemic vascular resistance, dilutional anemia, and mechanical venous compression.
Question 57Question →

Match each classic clinical presentation during a primary postpartum hemorrhage with its most likely underlying etiology.

Click a left item, then click its matching right item

Items

Soft, enlarged, 'boggy' uterus palpable above the umbilicus with heavy vaginal bleeding
Firm, well-contracted, midline uterus with a continuous steady trickle of bright red blood
Firm, contracted uterus with heavy bleeding; inspection of the delivered placenta shows a torn maternal surface
Severe pain, hemorrhagic shock, a visible beefy-red vaginal mass, and an absent uterine fundus on abdominal palpation

Matches

Show answer & explanation

Answer

The correct matches correctly align the classic physical exam findings with their respective postpartum hemorrhage etiologies: boggy uterus indicates atony, firm uterus with continuous bleeding indicates laceration, torn placenta indicates retained products, and an absent fundus indicates uterine inversion.
Each classic presentation maps specifically to the etiologies of postpartum hemorrhage: 'boggy' uterus to atony, firm uterus with continuous bleeding to lacerations, incomplete placenta to retained products, and absent fundus with vaginal mass to uterine inversion.

Step-by-Step Solution

1
Evaluate the state of the uterine tone on physical examination.
The presence of a soft or 'boggy' uterus indicates a loss of tone.
Uterine atony is the leading cause of postpartum hemorrhage and is diagnosed primarily by palpating a poorly contracted uterus.
2
Assess for bleeding in the setting of a firmly contracted uterus.
If the uterus is firm but active bleeding persists, trauma (lacerations) should be suspected.
Lacerations cause ongoing, often bright red bleeding that is independent of myometrial contraction.
3
Inspect the delivered placenta and the vaginal vault.
A torn maternal placental surface suggests retained tissue, whereas an absent fundus and a visible vaginal mass suggest uterine inversion.
Identifying these specific physical exam clues differentiates the remaining common causes of postpartum hemorrhage.

Key Concept

Differentiating the etiologies of primary postpartum hemorrhage based on classic physical examination findings.
Question 58Question →

A healthy 24-year-old primigravida presents for preconception counseling. She is subsequently confirmed pregnant and initiates prenatal care at 8 weeks gestation. Her initial laboratory workup reveals she is blood type A-negative. Assuming an uncomplicated pregnancy course that concludes with the term vaginal delivery of a healthy Rh(D)-positive neonate, arrange the following routine alloimmunization screening and prophylaxis steps in the correct chronological sequence from the first trimester through the postpartum period.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Initial prenatal ABO/Rh(D) blood typing and baseline maternal serum indirect antiglobulin testing, 2) Repeat maternal indirect antiglobulin testing to confirm the continued absence of alloimmunization, 3) Routine antepartum prophylactic administration of a standard 300-mcg dose of anti-D immune globulin, 4) Qualitative erythrocyte rosette testing on maternal blood to detect massive fetal-maternal hemorrhage, and 5) Postpartum administration of anti-D immune globulin with the dose adjusted via quantitative testing.
The correct chronological sequence for managing an Rh(D)-negative pregnant patient begins with an initial prenatal ABO/Rh(D) blood typing and baseline maternal serum indirect antiglobulin testing to establish baseline status. At 28 weeks gestation, repeat maternal indirect antiglobulin testing must be performed to confirm the continued absence of alloimmunization. Immediately following this blood draw, routine antepartum prophylactic administration of a standard 300-mcg dose of anti-D immune globulin is given. Postpartum, after delivery of an Rh(D)-positive neonate, qualitative erythrocyte rosette testing on maternal blood is performed to detect significant fetal-maternal hemorrhage. Finally, postpartum administration of anti-D immune globulin is given within 72 hours, with the dose adjusted based on quantitative testing (such as the Kleihauer-Betke test) if the initial qualitative screen was positive.

Step-by-Step Solution

1
Identify the baseline initial prenatal testing requirements for an unsensitized Rh(D)-negative pregnant patient.
Initial prenatal ABO/Rh(D) blood typing and baseline maternal serum indirect antiglobulin testing must be performed first to establish the lack of pre-existing antibodies.
A baseline must be established in the first trimester before any potential sensitization events occur.
2
Determine the required screening immediately prior to third-trimester prophylaxis.
A repeat maternal indirect antiglobulin test is required at 28 weeks gestation.
It is necessary to confirm the patient has not become sensitized during the pregnancy before administering the prophylactic immune globulin.
3
Administer the standard antepartum prophylaxis.
Routine antepartum prophylactic administration of a standard 300-mcg dose of anti-D immune globulin is given.
This provides passive immunity during the third trimester and must be given only AFTER the 28-week antibody screen is drawn to avoid an iatrogenic positive screen.
4
Identify the appropriate initial postpartum screening test following delivery of an Rh(D)-positive neonate.
Qualitative erythrocyte rosette testing is performed on maternal blood.
This screens for massive fetal-maternal hemorrhage > 30 mL to determine if a single standard dose of immune globulin is sufficient or if quantitative testing is needed.
5
Administer the final targeted prophylaxis.
Postpartum administration of anti-D immune globulin is given, dosed according to quantitative testing (e.g., Kleihauer-Betke) if the rosette test was positive.
Adequate dosing must be given within 72 hours postpartum to neutralize all fetal erythrocytes and prevent permanent maternal alloimmunization.

Key Concept

Rh(D) alloimmunization prevention requires a strict chronological sequence: initial first-trimester screening, repeat screening at 28 weeks prior to routine antepartum prophylaxis, and postpartum qualitative/quantitative fetal-maternal hemorrhage testing to guide the final postpartum prophylactic dose.
Estimated Time:1m 30s
Question 59Question →

Match the following clinical and laboratory findings observed during an uncomplicated normal pregnancy with their primary underlying physiological mechanisms.

Click a left item, then click its matching right item

Items

Arterial blood gas at 2828 weeks gestation showing pH 7.447.44, PaCO 2_2 2828 mmHg, and HCO 3−_3^- 1818 mEq/L
Serum creatinine of 0.50.5 mg/dL and 2424-hour urine protein of 260260 mg at 3030 weeks gestation
Decreased TSH (0.20.2 mU/L) and elevated total T 4_4 with normal free T 4_4 at 1010 weeks gestation
Platelet count of 115,000115,000/mm 3^3 with normal coagulation studies at 3636 weeks gestation
New-onset prominent S 3_3 gallop and grade 2/62/6 systolic ejection murmur at 3232 weeks gestation

Matches

Show answer & explanation

Answer

Each clinical and laboratory finding matches a specific hormonal and hemodynamic adaptation required to sustain a normal pregnancy.
Each correct match directly links a normal, expected clinical or laboratory finding during pregnancy to its underlying pathophysiological mechanism, demonstrating an understanding of how maternal adaptations safely mimic disease states.

Step-by-Step Solution

1
Analyze the arterial blood gas values (pH 7.447.44, PaCO 2_2 2828, HCO 3−_3^- 1818).
Identify a fully compensated respiratory alkalosis.
This is a normal physiological finding caused by increased central chemoreceptor sensitivity, driving higher tidal volume.
2
Evaluate the renal laboratory values (Cr 0.50.5, Protein 260260 mg).
Recognize normal pregnancy-induced hyperfiltration.
Vasodilation increases renal plasma flow and GFR, leading to lower serum creatinine and higher baseline proteinuria.
3
Interpret the thyroid panel (low TSH, high total T 4_4, normal free T 4_4).
Identify normal early-pregnancy thyroid adaptation.
hCG alpha-subunit cross-reacts with TSH receptors, while increased binding proteins (TBG) raise total T 4_4 without affecting the active free hormone.
4
Assess the isolated mild thrombocytopenia (115,000115,000/mm 3^3).
Diagnose gestational thrombocytopenia.
Normal hemodilution and increased peripheral clearance lower the platelet count without causing a bleeding diathesis.
5
Evaluate the cardiovascular exam findings (S 3_3, systolic murmur).
Recognize a benign physiological hyperdynamic state.
Decreased systemic vascular resistance triggers increased stroke volume, creating benign high-flow cardiac sounds.

Key Concept

Maternal physiological adaptations to pregnancy can mirror pathological disease states, requiring precise differentiation based on expected gestational thresholds.
Question 60Question →

A 2424-year-old woman, gravida 11, para 00, presents to the clinic at 88 weeks gestation for her initial prenatal visit. Her medical history is unremarkable, and she takes a daily prenatal vitamin. Her blood pressure is 112/70 mmHg112/70\text{ mmHg}, and her body mass index is 22 kg/m222\text{ kg/m}^2. The patient is eager to ensure a healthy pregnancy and asks the physician to outline the standard schedule of recommended screenings and evaluations she will undergo over the coming months.

Arrange the following routine obstetric interventions for this patient in the correct chronological order from earliest to latest gestational age.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Urine culture (initial visit), PAPP-A and nuchal translucency (1111-1414 weeks), Anatomic survey ultrasound (1818-2222 weeks), 50-g50\text{-g} oral glucose challenge test (2424-2828 weeks), and Vaginal-rectal swab for Group B Streptococcus (3636-3838 weeks).
Prenatal care follows a chronologic, evidence-based schedule designed to monitor maternal health and fetal development. At the initial visit (usually 88-1010 weeks), routine screening for asymptomatic bacteriuria is performed. Between 1111 and 1414 weeks, first-trimester aneuploidy screening (PAPP-A, free beta-hCG, and nuchal translucency) is offered. In the second trimester (1818-2222 weeks), a comprehensive fetal anatomic survey ultrasound is conducted. Between 2424 and 2828 weeks, patients undergo screening for gestational diabetes mellitus using a 50-g50\text{-g} 1-hour1\text{-hour} oral glucose challenge test. Finally, in the late third trimester (36 0/736\ 0/7 to 37 6/737\ 6/7 weeks), a combined vaginal-rectal swab is collected to screen for Group B Streptococcus (GBS) colonization to determine the need for intrapartum antibiotic prophylaxis.

Step-by-Step Solution

1
Identify the timing of the urine culture for asymptomatic bacteriuria.
Performed at the initial prenatal visit (first trimester, typically 88-1010 weeks).
Early detection and treatment prevent progression to pyelonephritis.
2
Identify the timing for first-trimester aneuploidy screening.
PAPP-A and nuchal translucency are measured between 1111 and 1414 weeks.
This specific window provides the most accurate risk assessment for trisomies 13, 18, and 21 before the second trimester.
3
Identify the timing for the fetal anatomic survey.
Comprehensive ultrasound is performed between 1818 and 2222 weeks.
Fetal structures are large enough to be clearly visualized, yet early enough to offer reproductive options if severe anomalies are detected.
4
Identify the timing for gestational diabetes screening.
The 50-g50\text{-g} oral glucose challenge test is performed between 2424 and 2828 weeks.
Placental secretion of diabetogenic hormones (e.g., human placental lactogen) peaks late in the second trimester, unmasking insulin resistance.
5
Identify the timing for Group B Streptococcus (GBS) screening.
Vaginal-rectal swab is collected between 3636 and 3838 weeks (specifically 36 0/736\ 0/7 to 37 6/737\ 6/7 weeks).
Screening within 5 weeks of expected delivery provides the highest negative predictive value for intrapartum colonization.

Key Concept

Routine prenatal care requires a standardized schedule of screenings to optimize maternal and fetal outcomes: initial visit (bacteriuria, standard labs), 1111-1414 weeks (aneuploidy screen), 1818-2222 weeks (anatomy ultrasound), 2424-2828 weeks (gestational diabetes screen), and 3636-3838 weeks (GBS screen).
PreviousPage 3 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 3 | Examkin